An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Jun 2023
Historique:
received: 25 05 2023
revised: 17 06 2023
accepted: 20 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited cardiomyopathy that follows an autosomal dominant inheritance pattern. The majority of HCM cases can be attributed to mutation of the MYBPC3 gene, which encodes cMyBP-C, a crucial structural protein of the cardiac muscle. The manifestation of HCM's morphological, histological, and clinical symptoms is subject to the complex interplay of various determinants, including genetic mutation and environmental factors. Approximately half of MYBPC3 mutations give rise to truncated protein products, while the remaining mutations cause insertion/deletion, frameshift, or missense mutations of single amino acids. In addition, the onset of HCM may be attributed to disturbances in the protein and transcript quality control systems, namely, the ubiquitin-proteasome system and nonsense-mediated RNA dysfunctions. The aforementioned genetic modifications, which appear to be associated with unfavorable lifelong outcomes and are largely influenced by the type of mutation, exhibit a unique array of clinical manifestations ranging from asymptomatic to arrhythmic syncope and even sudden cardiac death. Although the current understanding of the MYBPC3 mutation does not comprehensively explain the varied phenotypic manifestations witnessed in patients with HCM, patients with pathogenic MYBPC3 mutations can exhibit an array of clinical manifestations ranging from asymptomatic to advanced heart failure and sudden cardiac death, leading to a higher rate of adverse clinical outcomes. This review focuses on MYBPC3 mutation and its characteristics as a prognostic determinant for disease onset and related clinical consequences in HCM.

Identifiants

pubmed: 37445689
pii: ijms241310510
doi: 10.3390/ijms241310510
pmc: PMC10341819
pii:
doi:

Substances chimiques

Carrier Proteins 0
Cytoskeletal Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cardiovasc Res. 2019 Dec 1;115(14):1986-1997
pubmed: 31050699
Front Cardiovasc Med. 2021 Dec 23;8:766339
pubmed: 35004883
Life (Basel). 2022 Aug 30;12(9):
pubmed: 36143383
J Gen Physiol. 2013 Sep;142(3):241-55
pubmed: 23980194
J Cardiol. 2015 May;65(5):423-8
pubmed: 25123604
Arch Biochem Biophys. 1998 Oct 15;358(2):313-9
pubmed: 9784245
J Pharm Pract. 2020 Dec;33(6):846-855
pubmed: 31248331
Circ J. 2020 Sep 25;84(10):1846-1853
pubmed: 32830170
J Mol Cell Cardiol. 2016 Aug;97:82-92
pubmed: 27108529
Circulation. 2019 Feb 5;139(6):799-811
pubmed: 30586709
J Biol Chem. 2009 May 1;284(18):12318-27
pubmed: 19269976
Basic Res Cardiol. 2012 Jan;107(1):235
pubmed: 22189562
Circ Res. 1998 Jan 9-23;82(1):130-3
pubmed: 9440712
Cardiovasc Res. 2004 Aug 1;63(2):293-304
pubmed: 15249187
J Mol Cell Cardiol. 2021 Jan;150:101-108
pubmed: 33049255
Circulation. 2000 Mar 28;101(12):1396-402
pubmed: 10736283
Mol Ther Nucleic Acids. 2017 Jun 16;7:475-486
pubmed: 28624223
Eur J Hum Genet. 2015 Jul;23(7):922-8
pubmed: 25335496
Circ Res. 2023 Mar 3;132(5):628-644
pubmed: 36744470
Circ Heart Fail. 2021 Jan;14(1):e007022
pubmed: 33430602
ESC Heart Fail. 2018 Aug;5(4):716-723
pubmed: 29663722
Circ Res. 2011 Mar 18;108(6):751-64
pubmed: 21415409
PLoS One. 2019 Jun 14;14(6):e0217612
pubmed: 31199839
Gerontology. 2013;59(3):199-205
pubmed: 23363806
J Proteome Res. 2010 Apr 5;9(4):1843-53
pubmed: 20151718
Hum Mutat. 2008 Aug;29(8):1037-47
pubmed: 18454449
J Mol Cell Cardiol. 2003 Jun;35(6):623-36
pubmed: 12788380
JCI Insight. 2018 Jun 7;3(11):
pubmed: 29875314
Cardiovasc Pathol. 2018 Nov - Dec;37:30-33
pubmed: 30282064
Open Heart. 2020 Apr 5;7(1):e001220
pubmed: 32341788
Sci Rep. 2022 Nov 5;12(1):18799
pubmed: 36335106
J Mol Cell Cardiol. 2016 May;94:65-71
pubmed: 27021517
Open Heart. 2021 Sep;8(2):
pubmed: 34588271
Pflugers Arch. 2019 May;471(5):781-793
pubmed: 30456444
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32750038
Cardiovasc Res. 2006 Jun 1;70(3):410-21
pubmed: 16497285
Sci Rep. 2022 May 4;12(1):7284
pubmed: 35508642
Eur J Med Genet. 2020 Mar;63(3):103754
pubmed: 31513939
J Mol Cell Cardiol. 2015 Feb;79:234-43
pubmed: 25463273
Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):661-677
pubmed: 30611859
Clin Res Cardiol. 2021 Apr;110(4):544-554
pubmed: 32880676
Circ Genom Precis Med. 2020 Oct;13(5):396-405
pubmed: 32841044
N Engl J Med. 2011 Apr 28;364(17):1643-56
pubmed: 21524215
J Mol Cell Cardiol. 2016 Oct;99:197-206
pubmed: 27620334
J Biol Chem. 2015 Feb 27;290(9):5855-67
pubmed: 25583989
Genome. 2011 Feb;54(2):120-7
pubmed: 21326368
Biophys Rev. 2012 Jun 1;4(2):93-106
pubmed: 22707987
Circulation. 2019 Mar 19;139(12):1559-1560
pubmed: 30883221
J Biol Chem. 2021 Jul;297(1):100854
pubmed: 34097875
Diagnostics (Basel). 2022 May 03;12(5):
pubmed: 35626289
Annu Rev Biochem. 2007;76:51-74
pubmed: 17352659
J Gen Physiol. 2023 Apr 3;155(4):
pubmed: 36893011
Circulation. 2009 Mar 24;119(11):1473-83
pubmed: 19273718
JCI Insight. 2020 Jan 30;5(2):
pubmed: 31877118
Sci Rep. 2015 Jun 19;5:11411
pubmed: 26090888
Cardiovasc Res. 2010 Jan 15;85(2):330-8
pubmed: 19617224
Nat Commun. 2022 Jul 6;13(1):3895
pubmed: 35794153
ACS Nano. 2021 Jun 22;15(6):10203-10216
pubmed: 34060810
Nat Commun. 2014 Dec 02;5:5515
pubmed: 25463264
Circ Genom Precis Med. 2019 Jan;12(1):e002368
pubmed: 30645170
Circ Res. 2021 May 14;128(10):1533-1553
pubmed: 33983830
Circ Cardiovasc Genet. 2012 Apr 1;5(2):156-66
pubmed: 22267749
Cardiovasc Res. 2015 Apr 1;105(4):457-70
pubmed: 25634554
Genetics. 2005 Apr;169(4):1915-25
pubmed: 15716499
J Cardiovasc Transl Res. 2020 Oct;13(5):867-877
pubmed: 32034629
Int J Cardiovasc Imaging. 2021 Jun;37(6):2001-2010
pubmed: 33559798
Science. 2015 May 8;348(6235):666-9
pubmed: 25954003
Circ Res. 2009 Jul 31;105(3):219-22
pubmed: 19574547
J Med Genet. 2022 Aug;59(8):768-775
pubmed: 34400558
PLoS One. 2017 Nov 9;12(11):e0187948
pubmed: 29121657
Cardiovasc Res. 2017 Aug 01;113(10):1124-1136
pubmed: 28371863
Medicina (Kaunas). 2021 Mar 18;57(3):
pubmed: 33803538
Eur J Hum Genet. 2004 Aug;12(8):673-7
pubmed: 15114369
PLoS One. 2017 Jun 28;12(6):e0180064
pubmed: 28658286
FEBS Lett. 2022 Mar;596(6):703-746
pubmed: 35224729
Circ Cardiovasc Genet. 2010 Apr;3(2):155-61
pubmed: 20215591
Int J Cardiol. 2019 Mar 1;278:173-179
pubmed: 30554928
Circ Cardiovasc Genet. 2014 Aug;7(4):434-43
pubmed: 25031304
Cardiovasc Res. 2003 Nov 1;60(2):388-96
pubmed: 14613868
Int J Mol Sci. 2023 Feb 17;24(4):
pubmed: 36835444
RNA Biol. 2014;11(9):1122-36
pubmed: 25483043
Sci Rep. 2019 Apr 11;9(1):5960
pubmed: 30976029
J Mol Cell Cardiol. 2016 Nov;100:54-63
pubmed: 27721024
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1782-92
pubmed: 11247792
Circ Res. 2009 Jul 31;105(3):239-48
pubmed: 19590044
Nat Genet. 2009 Feb;41(2):187-91
pubmed: 19151713
Eur Heart J. 2015 May 7;36(18):1123-35a
pubmed: 25163546
Gene. 2015 Dec 1;573(2):188-97
pubmed: 26358504
Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):932-938
pubmed: 30668650
Am J Physiol Heart Circ Physiol. 2018 Jun 1;314(6):H1179-H1191
pubmed: 29451820
Heart Rhythm. 2012 Jan;9(1):57-63
pubmed: 21839045
Circ Res. 1997 Mar;80(3):427-34
pubmed: 9048664
Genet Med. 2021 Jul;23(7):1281-1287
pubmed: 33782553
Sci Transl Med. 2019 Jan 23;11(476):
pubmed: 30674652
Circ Genom Precis Med. 2020 Jun;13(3):e002905
pubmed: 32396390
BMC Cardiovasc Disord. 2020 Dec 9;20(1):516
pubmed: 33297970

Auteurs

Bogdan-Sorin Tudurachi (BS)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Alexandra Zăvoi (A)

Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Andreea Leonte (A)

Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Laura Țăpoi (L)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Carina Ureche (C)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Silviu Gabriel Bîrgoan (SG)

Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Traian Chiuariu (T)

Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Larisa Anghel (L)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Rodica Radu (R)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Radu Andy Sascău (RA)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Cristian Stătescu (C)

Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Prof. Dr. George I.M. Georgescu Institute of Cardiovascular Diseases, Carol I Boulevard, No. 50, 700503 Iasi, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH